UNITED STATES SECURITIES AND EXCHANGE COMMISSION

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT ~~Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934~~

~~Date~~Pursuant ofto ~~Report: November~~Section ~~10,~~13 ~~2003~~ or 15(~~Date~~d) of ~~earliest event reported)~~

the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported)		November 13, 2003

CYGNUS, INC.

(Exact ~~name~~Name of ~~registrant~~Registrant as ~~specified~~Specified in ~~its~~ Charter)

0-18962 (Commission file number)


Delaware	0-18962	94-2978092

(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

DELAWARE		94-2978092
400 Penobscot Drive, Redwood City, California		94063-4719
(State or other jurisdiction of incorporation)		(IRS Employer Identification No.)
(Address of Principal Executive Offices)		(Zip Code)

~~400~~Registrant’s ~~Penobscot~~telephone ~~Drive Redwood City~~number, ~~California (Address of principal executive offices~~ including ~~zip~~area code (650) 369-4300

~~(650) 369-4300 (Registrant’s~~Not ~~telephone number, including area code)~~Applicable

~~N/A~~(Former Name or Former Address, if Changed Since Last Report)

(Former name or former address, if changed since last report)

TABLE OF CONTENTS

	Item 7. Financial Statements and Exhibits.
	Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
	Item 9. Regulation FD Disclosure.
	Item 12. Results of Operations and Financial Condition.
SIGNATURE
SIGNATURES
Index to Exhibits
Exhibit Index
EXHIBIT 99.1

Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.

(c)

Exhibits.

Exhibit Number 99.1 Press Release ~~issued~~ by Cygnus, Inc. ondated November 1013, 2003 referred to in Item 5 above.

Item 912. ~~Regulation FD~~Results ~~Disclosure~~of Operations and Financial Condition.

On November 1013, 2003, Cygnus, Inc. (“Cygnus”) issued aan ~~press~~earnings release announcing ~~the~~its ~~restructuring~~financial ofresults for the ~~remaining~~quarter ~~royalty~~ended ~~payments~~September 30, ~~owed~~2003. toA ~~Sanofi~Synthelabo~~copy ~~pursuant~~of toCygnus’ aearnings ~~1997~~release ~~Final~~is ~~Arbitration~~attached ~~Award~~hereto as Exhibit 99.1.

Cygnus also announced that on November 6, 2003 Sankyo Pharma filed an answer and cross-claims against Cygnus for declaratory relief, breach of contract, and defamation in response to the Company’s lawsuit filed on October 6, 2003.

The information contained in this Form 8-K is being furnished and presented under Item 9 of Form 8-K and should not be deemed “filed” for purposes of the Securities Exchange Act of 1934, as amended. Furthermore, the information in this Current Report on Form 8-K, including the exhibit, shall not be deemed to be incorporated by reference into the filings of Cygnus under the Securities Act of 1933, as amended.

~~SIGNATURE~~SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: November 10, 2003	CYGNUS, INC
			CYGNUS, INC
	By:	/s/Barbara G. McClung
Date:	November 13, 2003	By:	/s/ Barbara G. McClung
		~~Barbara G. McClung Senior Vice President and General Counsel~~	Barbara G. McClung Senior Vice President and General Counsel

Exhibit Index ~~to Exhibits~~

Exhibit
Number		Description
99.1		Press Release issued by Cygnus, Inc. on November 10, 2003.


			99.1			Press Release by Cygnus, Inc. dated November 13, 2003 referred to in Item 5 above.

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Filing Compare · CYGNUS INC /DE/